Kimberly A. Walters

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

Daniel S. Ory, Elizabeth A. Ottinger, Nicole Y. Farhat et al. · The Lancet · 2017 · 316 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Clinical Therapeutic +9

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Glenn M. Chertow, Pablo E. Pérgola, Youssef M.K. Farag et al. · New England Journal of Medicine · 2021 · 231 citations · Full text

Impact of Multifamily Psychoeducational Psychotherapy in Treating Children Aged 8 to 12 Years With Mood Disorders

Mary A. Fristad, Joseph S. Verducci, Kimberly A. Walters et al. · Archives of General Psychiatry · 2009 · 214 citations

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

Kai‐Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad et al. · New England Journal of Medicine · 2021 · 185 citations · Full text

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher et al. · Nature Medicine · 2022 · 57 citations · Full text